Published on 20/11/2020 11:44:14 AM | Source: ICICI Securities

Insurance Sector Update - Rising Covid claims will increase H2FY21 health loss ratios By ICICI Securities

Posted in Broking Firm Views - Sector Report| #Insurance Sector #Sector Report #ICICI Securities

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel 

Download Telegram App before Joining the Channel

Rising Covid claims will increase H2FY21 health loss ratios

Rising Covid claims against the backdrop of normalisation in non-Covid claims is set to put health loss ratios under pressure in H2FY21. While exponential increase in Covid claims will lead to cut in earnings estimates, well-funded insurers stand to gain market share in health insurance in the longer run.

* Covid claims on exponential rise: From US$24mn in June, claims in this segment have risen to US$362mn by end of August. The exponential increase is evident from the perspective that total Covid claim amount till June-end was US$75mn while July added US$78mn and August US$209mn.

* Till August, total Covid claim amount is estimated at ~11% of non-life health GDPI. Industry health GDPI till July has been ~Rs184bn while July health GDPI was Rs50bn. Assuming August was similar at Rs50bn, the total health GDPI till Augustend works out to Rs234bn (US$3.2bn). Hence, total Covid-related claims till Augustend was ~11% of the total health GDPI. It could be higher as a share of health NEP depending on reinsurance arrangements. However, industry reports suggest that reinsurers are hesitant to underwrite the Covid risk. This has been a major challenge for pricing of insurance policies covering Covid treatment.

* H2FY21 health loss ratios will worsen as non-Covid claims normalise. While non-Covid claims have been lower in H1FY21, the non-Covid counterpart is reportedly close to pre-Covid levels now. Even if we assume that Covid claims maintain a run rate of US$150mn per month from September, the total FY21 Covid claim amount would be ~US$1.4bn (Rs105bn). At 5.5% health market share (Q1FY20), ICICI Lombard (ICICIGI) FY21 Covid claim would be Rs5.7bn. Assuming ICICIGI retains 80% of its health business, accountable Covid loss could be Rs4.6bn. While some reserving may have already been done (75% loss ratio in Q1FY21 vs 70% in FY20), increasing Covid claims pose upside risk to this estimate.

* Insurers with strong balance sheet will gain health market share. It follows from the above that ICICIGI will structurally gain despite lower profitability in FY21. In many ways, non-life insurance industry is at a cyclical trough (no motor TP price hikes in FY21, persistent pressure in motor OD rates, lower auto sales and higher health loss ratios). High-quality private non-life players therefore stand to benefit more on cycle recovery


To Read Complete Report & Disclaimer Click Here


For More ICICI Securities Disclaimer


Above views are of the author and not of the website kindly read disclaimer